Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome
- PMID: 10465108
- PMCID: PMC1762963
Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome
Abstract
Background: We have sought to establish the prevalence of goitre within a Pendred syndrome (PS) cohort and to document the course of thyroid disease in this patient group. As part of a genetic study of PS we have assessed 57 subjects by perchlorate discharge test and in 52 (M 21, F 31, age range 9-54 years) a discharge of radioiodide of >10% was observed.
Results: Goitre was present in 43 (83%) of the cohort (28 F, 15 M), generally developing after the age of 10 years, 56% remained euthyroid (age range 9-37 years), and 19 patients (44%) had objective evidence of hypothyroidism, all of whom had goitre.
Conclusions: In summary, thyroid dysfunction in PS is variable and inclusion of goitre as a diagnostic requirement will maintain significant underascertainment. The recent identification of the genetic defect underlying PS is likely to provide an important diagnostic aid in the identification of this disorder and this communication should assist clinicians in identifying deaf patients who ought to be considered for this investigation.
Similar articles
-
Thyroid disorders in Khulna district: a community based study.Bangladesh Med Res Counc Bull. 2006 Dec;32(3):66-71. Bangladesh Med Res Counc Bull. 2006. PMID: 17867270
-
[Pendred syndrome as a cause of familial deafness].Acta Otorrinolaringol Esp. 1999 Aug-Sep;50(6):477-9. Acta Otorrinolaringol Esp. 1999. PMID: 10502702 Review. Spanish.
-
Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification.Nat Genet. 1996 Apr;12(4):424-6. doi: 10.1038/ng0496-424. Nat Genet. 1996. PMID: 8630498
-
Pendred syndrome--100 years of underascertainment?QJM. 1997 Jul;90(7):443-7. doi: 10.1093/qjmed/90.7.443. QJM. 1997. PMID: 9302427
-
Syndromic and non-syndromic deafness, molecular aspects of Pendred syndrome and its reported mutations.J Ayub Med Coll Abbottabad. 2003 Jul-Sep;15(3):59-64. J Ayub Med Coll Abbottabad. 2003. PMID: 14727345 Review.
Cited by
-
Auditory disorders and future therapies with delivery systems.J Tissue Eng. 2018 Oct 30;9:2041731418808455. doi: 10.1177/2041731418808455. eCollection 2018 Jan-Dec. J Tissue Eng. 2018. PMID: 30397431 Free PMC article. Review.
-
Evaluation of the thyroid in patients with hearing loss and enlarged vestibular aqueducts.Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):670-6. doi: 10.1001/archoto.2009.66. Arch Otolaryngol Head Neck Surg. 2009. PMID: 19620588 Free PMC article.
-
Perchlorate clinical pharmacology and human health: a review.Ther Drug Monit. 2001 Aug;23(4):316-31. doi: 10.1097/00007691-200108000-00002. Ther Drug Monit. 2001. PMID: 11477312 Free PMC article. Review.
-
Molecular analysis of hearing loss associated with enlarged vestibular aqueduct in the mainland Chinese: a unique SLC26A4 mutation spectrum.J Hum Genet. 2007;52(6):492-497. doi: 10.1007/s10038-007-0139-0. Epub 2007 Apr 19. J Hum Genet. 2007. PMID: 17443271
-
Congenital goitrous hypothyroidism, deafness and iodide organification defect in four siblings: Pendred or pseudo-Pendred syndrome?J Clin Res Pediatr Endocrinol. 2010;2(2):81-4. doi: 10.4274/jcrpe.v2i2.81. Epub 2010 May 6. J Clin Res Pediatr Endocrinol. 2010. PMID: 21274344 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials